Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hyman

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|March 16, 2011
Adapting to decreased industry support of CME: lifelong education in an "industry-lite" worldJoel Yager, Joel J Silverman, Mark Hyman Rapaport
The American Journal of Psychiatry|June 3, 2005
Quality-of-life impairment in depressive and anxiety disordersMark Hyman Rapaport, Cathryn Clary, Rana Fayyad, et al.
The American Journal of Psychiatry|January 5, 2013
A simple question answered: adding moderate-dosage lithium does not help patients with bipolar disorderBoadie W Dunlop, Jeffrey J Rakofsky, Mark Hyman Rapaport
Journal of Clinical Psychopharmacology|December 27, 2011
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorderLev Gertsik, Russell E Poland, Catherine Bresee, et al.
Brain, Behavior, and Immunity|December 28, 2014
Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychosesBrian J Miller, Prianka Kandhal, Mark Hyman Rapaport, et al.
Bipolar Disorders|March 17, 2012
Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot studyAlexander Fan, Andrew Berg, Catherine Bresee, et al.
Journal of Sports Sciences|December 12, 2018
Association between relative age effect and organisational practices of American youth footballCiera Jones, Amanda J Visek, Mary J Barron, et al.
Plos One|June 7, 2019
The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical programGabriella Waserstein, Clyde Partin, Debra Cohen, et al.
Plos One|October 8, 2020
The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective studyNicole Droz, Patrick Hanaway, Mark Hyman, et al.
The Journal of Clinical Psychiatry|November 25, 2003
Efficacy of controlled-release paroxetine in the treatment of late-life depressionMark Hyman Rapaport, Lon S Schneider, David L Dunner, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|March 16, 2011
Adapting to decreased industry support of CME: lifelong education in an "industry-lite" worldJoel Yager, Joel J Silverman, Mark Hyman Rapaport
The American Journal of Psychiatry|June 3, 2005
Quality-of-life impairment in depressive and anxiety disordersMark Hyman Rapaport, Cathryn Clary, Rana Fayyad, et al.
The American Journal of Psychiatry|January 5, 2013
A simple question answered: adding moderate-dosage lithium does not help patients with bipolar disorderBoadie W Dunlop, Jeffrey J Rakofsky, Mark Hyman Rapaport
Journal of Clinical Psychopharmacology|December 27, 2011
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorderLev Gertsik, Russell E Poland, Catherine Bresee, et al.
Brain, Behavior, and Immunity|December 28, 2014
Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychosesBrian J Miller, Prianka Kandhal, Mark Hyman Rapaport, et al.
Bipolar Disorders|March 17, 2012
Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot studyAlexander Fan, Andrew Berg, Catherine Bresee, et al.
Journal of Sports Sciences|December 12, 2018
Association between relative age effect and organisational practices of American youth footballCiera Jones, Amanda J Visek, Mary J Barron, et al.
Plos One|June 7, 2019
The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical programGabriella Waserstein, Clyde Partin, Debra Cohen, et al.
Plos One|October 8, 2020
The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective studyNicole Droz, Patrick Hanaway, Mark Hyman, et al.
The Journal of Clinical Psychiatry|November 25, 2003
Efficacy of controlled-release paroxetine in the treatment of late-life depressionMark Hyman Rapaport, Lon S Schneider, David L Dunner, et al.
Pageof 8